A transient neutrophilic chemotactic deficit was confirmed in a 3 1/2-year-old castrated male dog with recurrent staphylococcal pyoderma accompanied by a persistent eosinophilia and intermittent basophilia. Neutrophilic chemotaxis was quantitatively assessed over the next seven months, and the disappearance of the chemotactic deficit correlated with complete clinical remission of the skin lesions. Aberrations of the complement system were not discovered, and the dog's serum showed increased chemoattractiveness for control neutrophil preparations.
References
1.
AlthausD.KellerH.U.HessM.W.CottierH.:
Impaired neutrophil locomotion during acute bacterial infections.
Int Arch Allergy Appl Immunol61:
321–328,
1980.
2.
AndersonR.GloverA.KoornhofH.J.RabsonA.R.:
In vitro stimulation of neutrophil motility by levamisole: Maintenance of cGMP levels in chemotactically stimulated levamisole-treated neutrophils.
J Immunol117:
428–432,
1976.
3.
AndersonR.GrabowG.OosthuizenR.TheronA.Van RensburgA.J.:
Effects of sulfamethoxalone and trimethoprim on human neutrophil and lymphocyte functions in vitro: In vivo effects of co-trimoxazole.
Antimicrob Agents Chemother17:
322–326,
1980.
4.
BlumR.GillerG.FishL.A.:
Recurrent severe staphylococcal infections, eczematoid rash, extreme elevations of IgE, eosinophilia, and divergent chemotactic response in two generations,
J Pediatr90:
607–609,
1977.
5.
CampbellD.H.GarveyJ.S.CremerN.E.SusdorfD.H.:
Methods in Immunology,
pp. 260–271,
4th ed.W. A. Benjamin, New York,
1970.
6.
ChristouN.V.MeakinsJ.L.:
Neutrophil function in anergic surgical patients: Neutrophil adherence and chemotaxis.
Ann Surg190:
557–564,
1979.
7.
DahlM.V.GreenW.H.QuieP.G.:
Infection, dermatitis, IgE, and impaired neutrophil chemotaxis: A possible relationship.
Arch Dermatol112:
1387–1390,
1976.
8.
GallinJ.I.ClarkR.A.FrankM.M.:
Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.
Clin Immunol Immunopathol3:
334–346,
1975.
9.
HakanssonL.VengeP.:
The influence of serum of random migration and chemotaxis of polymorphonuclear leucocytes: Methodological evaluation using sera from infection-prone patients and normals.
Scand J Immunol11:
271–282,
1980.
HillH.R.EstensonR.D.HoganN.A.QuieP.G.:
Severe staphylococcal disease associated with allergic manifestations, hyperimmunoglobulinemia E, and defective neutrophil chemotaxis.
J Lab Clin Med88:
796–806,
1976.
12.
HillH.R.GerrardJ.M.HoganN.A.QuieP.G.:
Hyperactivity of neutrophil leukotactic responses during active bacterial infection.
J Clin Invest53:
996–1002,
1974.
13.
HillH.R.WilliamsP.B.KruegerG.G.JanisB.:
Recurrent staphylococcal abscesses associated with defective neutrophil chemotaxis and rhinitis.
Ann Intern Med85:
39–43,
1976.
14.
IssekutzA.C.LeeK.Y.BiggarW.D.:
Neutrophil chemotaxis in two patients with recurrent staphylococcal skin infections and hyperimmunoglobulin E.
J Lab Clin Med92:
640–647,
1978.
15.
JeuneR.FaureM.Leung-TackJ.SchmittD.ThivoletJ.:
Defective leukocytotaxia and recurrent staphylococcal infection: Deficiency of leukocytotaxia, increased serum IgE levels in an adult with recurrent staphylococcal infections.
Arch Dermatol114:
1372–1378,
1978.
16.
LatimerK.S.CraneL.S.PrasseK.W.:
Quantitative evaluation of neutrophilic chemotaxis in beagles.
Am J Vet Res,
42:
1254–1256,
1981.
17.
MacGregorR.R.SpangnuoloP.J.LentnekA.L.:
Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with an assay system.
N Engl J Med291:
642–646,
1974.
18.
MowatA.G.BaumJ.:
Polymorphonuclear leukocyte chemotaxis in patients with bacterial infections.
Br Med J3:
617–619,
1971.
19.
QuieP.G.CatesK.L.:
Clinical manifestations of disorders of neutrophil chemotaxis. In:
Leukocyte Chemotaxis: Methods, Physiology and Clinical Implications.
ed. GallinQuie,
pp. 307–328.
Raven Press, New York,
1978.
20.
RobinsonL.D.WootenS.K.KellyA.P.:
Identification of a neutrophil chemotactic inhibitor in a patient with recurrent pyoderma.
Arch Dermatol115:
453–457,
1979.
21.
SacchettiC.PatroneF.DallegriF.:
Neutrophil chemotaxis: physiology and pathology.
Haematologica (Pavia)63:
696–714,
1978.
22.
SchmelingD.J.PetersonP.K.BarrI.M.KimY.QuieP.G.:
Chemotaxogenesis by encapsulated Staphylococcus aureus M.
Infect Immun27:
700–703,
1980.
23.
SchopferK.BaerlocherK.PriceP.KrechU.QuieP.G.DouglasS.D.:
Staphylococcal IgE antibodies, hyperimmunoglobulinemia E, and Staphylococcus aureus infections.
N Engl J Med300:
835–838,
1979.
24.
WalkerW.S.BarletR.L.KurtzH.M.:
Isolation and partial characterization of a staphylococcal leukocyte cytotaxin.
J Bacteriol97:
1005–1008,
1969.
25.
WardP.A.CochraneC.G.Müller-EberhardH.J.:
The role of serum complement in chemotaxis of leukocytes in vitro.
J Exp Med122:
327–346,
1965.
26.
WardP.A.GoralnikS.BullockW.E.:
Defective leukotaxis in patients with lepromatous leprosy.
J Lab Clin Med87:
1025–1032,
1976.
27.
WardenG.D.MasonA.D.PruittB.A.:
Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries.
Ann Surg181:
363–369,
1975.
28.
WilkinsonB.J.KimY.PetersonP.K.QuieP.G.MichaelA.F.:
Activation of complement by cell surface components of Staphylococcus aureus.
Infect Immun20:
388–392,
1978.
29.
WilliamsC.A.ChaseM.W.:eds
Immunology and Immunochemistry,
pp. 134–153,
Vol. IV.
Academic Press, New York,
1977.
30.
WilsonL.BamburgJ.R.MizelS.B.GirshmanL.M.CreswellK.M.:
Interaction of drugs with microtubule proteins.
Fed Proc33:
158–166,
1974.
